AUS
NZ
UK
CA
USA
IND
Highlights
Vest Financial LLC expanded its position in AbbVie Inc. (NYSE:ABBV) during the fourth quarter, acquiring an additional 22,502 shares.
Other institutional investors, including State Street Corp and Assenagon Asset Management S.A., have also increased their holdings.
Institutional investors and hedge funds collectively own over 70% of AbbVie's outstanding shares.
Institutional Investments in AbbVie
AbbVie operates within the pharmaceutical sector, focusing on developing and marketing innovative treatments. Recent filings indicate that Vest Financial LLC increased its holdings in the company by acquiring 22,502 additional shares, bringing its total ownership to 308,782 shares. The latest filings with the Securities & Exchange Commission show that the firm’s stake in AbbVie was valued at approximately $54,871,000 at the end of the last quarter.
Broader Institutional Activity
Beyond Vest Financial LLC, several other institutional investors have expanded their positions in AbbVie. International Assets Investment Management LLC significantly increased its stake in the third quarter. The firm now holds 4,728,063 shares after acquiring an additional 4,471,806 shares, with an estimated value exceeding $933 million.
State Street Corp also raised its stake in AbbVie, adding 1,267,685 shares in the third quarter. The firm now holds approximately 79,067,935 shares, with a valuation exceeding $15.6 billion. Assenagon Asset Management S.A. followed a similar pattern, increasing its holdings by 59.5% through the acquisition of 781,858 additional shares. The firm now owns 2,096,858 shares, valued at approximately $414 million.
Other Notable Shareholder Changes
UBS Asset Management Americas LLC has expanded its position in AbbVie as well. The firm added 582,953 shares, bringing its total ownership to 10,175,926 shares, valued at over $2 billion. Another institutional investor, Saturna Capital Corp, increased its holdings by 486.1% in the third quarter. The firm now owns 676,176 shares after acquiring 560,808 additional shares, with an estimated value of $133.5 million.
Institutional Ownership Trends
With institutional investors and hedge funds collectively owning more than 70% of AbbVie’s outstanding shares, the company continues to attract attention from large-scale investment firms. These transactions suggest a trend of increasing confidence among institutional investors regarding AbbVie’s role in the pharmaceutical sector.
Conclusion
The increased institutional participation in AbbVie (NYSE:ABBV) highlights its relevance in the pharmaceutical industry. As firms adjust their holdings, changes in institutional ownership reflect broader trends within the sector.
